EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular epidemiology and pharmacokinetic–pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain

María Del Rosario Almela-Ferrer, María Carmen Nieto-Toboso, Elisabeth Montoya-Azpeitia, Josefina López-de Munain, Leonora Hernández-Ragpa, Inigo Gorostiza, Alicia Rodríguez-Gascón, Mikel Urrutikoetxea-Gutiérrez, Andrés Canut-Blasco, Sofía Ibarra-Ugarte, José Luis Díaz de Tuesta-Del Arco, Ramón Cisterna-Cancer und 1 weitere

European Journal of Clinical Microbiology & Infectious Diseases · 2026

DOI: 10.1007/s10096-026-05591-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2026. Verfasst von María Del Rosario Almela-Ferrer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Basurto University Hospital, Osakidetza Basque Health Service, Bilbao, Spain. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Gonorrhea, Anti-Bacterial Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad del País Vasco.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To analyse the epidemiology, antimicrobial susceptibility and molecular diversity of Neisseria gonorrhoeae isolates recovered in 2016–2017 at a tertiary hospital in northern Spain, and to perform a seven-year pharmacokinetic/pharmacodynamic (PK/PD) evaluation using susceptibility data from previous studies conducted in the same hospital setting.

Methods

A total of 231 non-duplicated isolates from 227 patients were studied. Antimicrobial susceptibility was determined by MIC gradient strip tests and molecular typing was performed by NG-MAST v2.0. Epidemiological variables were analysed, and considering the MIC distribution of the isolates, the cumulative fraction of response (CFR) for relevant antimicrobials was estimated.

Results

Most infections occurred in men (80.5%), particularly among men who have sex with men (50.3%), with the highest incidence in patients aged 25–34 years. All isolates were susceptible to ceftriaxone and cefixime (100%), while susceptibility to azithromycin remained above 95% throughout the study period. In contrast, ciprofloxacin resistance remained high, ranging from 46.2% to 72.7% over the seven-year period. PK/PD analysis showed that CFR values ≥ 90% were achieved only with cephalosporins. Molecular typing identified 91 STs, including 15 previously undescribed STs. Six genogroups accounted for 51.9% of isolates and were associated with distinct epidemiological and resistance patterns.

Conclusion

Ceftriaxone remains the preferred empirical treatment option for gonococcal infection. The favourable PK/PD performance observed for cefixime supports its activity against the studied isolates, although current treatment recommendations continue to prioritize ceftriaxone, particularly for extragenital infections; whereas ciprofloxacin should not be recommended for empirical use because of persistently high resistance rates. Continued molecular and antimicrobial resistance surveillance is essential for monitoring the emergence and dissemination of NG-MAST genogroups associated with antimicrobial resistance and for guiding future treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeGonorrheaAnti-Bacterial AgentsHumansMaleSpainAdultMicrobial Sensitivity TestsMolecular EpidemiologyFemaleMiddle AgedThird Generation CephalosporinsYoung AdultMolecular TypingDrug Resistance, BacterialSecond Generation CephalosporinsAdolescentAged

Stichwörter der Autor:innen

Neisseria gonorrhoeaeAntimicrobial resistanceCeftriaxoneGonorrhoeaNG-MASTPharmacodynamics

Substanzen

Anti-Bacterial AgentsThird Generation CephalosporinsSecond Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Basurto University Hospital, Osakidetza Basque Health Service, Bilbao, Spain.
  • Microbiology Infection Control Group, Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.
  • Department of Infectious Diseases, Basurto University Hospital, Osakidetza Basque Health Service, Bilbao, Spain.
  • Clinical Research in Infectious Diseases Group, Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.
  • Research Unit, Basurto University Hospital, Osakidetza Basque Health Service, Bilbao, Spain.
  • Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, University of the Basque Country, Vitoria-Gasteiz, Spain.

Förderung

  • Universidad del País Vasco

Zitieren

APA

Almela-Ferrer, M. D. R., Nieto-Toboso, M. C., Montoya-Azpeitia, E., López-de Munain, J., Hernández-Ragpa, L., Gorostiza, I., Rodríguez-Gascón, A., Urrutikoetxea-Gutiérrez, M., Canut-Blasco, A., Ibarra-Ugarte, S., Díaz de Tuesta-Del Arco, J. L., Cisterna-Cancer, R., & Basaras-Ibarzabal, M. (2026). Molecular epidemiology and pharmacokinetic–pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-026-05591-5

Vancouver

Almela-Ferrer MDR, Nieto-Toboso MC, Montoya-Azpeitia E, López-de Munain J, Hernández-Ragpa L, Gorostiza I, et al. Molecular epidemiology and pharmacokinetic–pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain. European Journal of Clinical Microbiology & Infectious Diseases. 2026. doi:10.1007/s10096-026-05591-5

BibTeX
@article{AlmelaFerrer2026,
  author = {Almela-Ferrer, María Del Rosario and Nieto-Toboso, María Carmen and Montoya-Azpeitia, Elisabeth and López-de Munain, Josefina and Hernández-Ragpa, Leonora and Gorostiza, Inigo and Rodríguez-Gascón, Alicia and Urrutikoetxea-Gutiérrez, Mikel and Canut-Blasco, Andrés and Ibarra-Ugarte, Sofía and Díaz de Tuesta-Del Arco, José Luis and Cisterna-Cancer, Ramón and Basaras-Ibarzabal, Miren},
  title = {Molecular epidemiology and pharmacokinetic–pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2026},
  doi = {10.1007/s10096-026-05591-5}
}
Kostenlos starten →